Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.
Support for your antifungal stewardship programme
Despite being less common than bacterial infections, invasive fungal infections (IFIs) represent an important clinical threat, with a significant health and financial burden.1
This page contains a range of resources designed to support the implementation of an antifungal stewardship programme. Please see below for video content detailing the considerations and experience of several healthcare professionals involved in antifungal stewardship programmes.
Lisa Nwankwo, Specialist Pharmacist Antimicrobials
Putting the pieces together: practical approaches to implementing successful antifungal stewardship
Dr David Enoch, Consultant Microbiologist
Clinical evidence and practical experience in the management of invasive fungal infections
Nelun Perera, Consultant Microbiologist
Considerations in antifungal stewardship and UK experiences: a microbiologist’s perspective
Explore more
Invasive Aspergillosis + ICU
An overview of invasive aspergillosis in the ICU setting.
Learn more
Diagnostic Driven Approach
Information about diagnostic-driven treatment approaches in the management of invasive fungal infections.
Learn more
Prescribing Information
Cresemba (isavuconazole)
Great Britain
Cresemba (isavuconazole) 100mg hard capsules
Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion
Northern Ireland
Cresemba (Isavuconazole) 100mg hard capsules and Cresemba (Isavuconazole) 200mg powder for concentrate for solution for infusion
Vfend (voriconazole)
Great Britain
Vfend (voriconazole) 50mg film coated tablets
Vfend (voriconazole) 200mg film coated tablets
Vfend (voriconazole) 200mg powder for solution for infusion
Vfend (voriconazole) 40mg/ml powder for oral suspension
Northern Ireland
Vfend (voriconazole): 50mg film coated tablets, 200mg film coated tablets, 200mg powder for solution for infusion & 40mg/ml powder for oral suspension
Meronem (meropenem) IV 1g
Meronem (meropenem) IV 500mg
Ecalta® (anidulafungin) 100mg powder for concentrate for solution for Infusion
Diflucan® (fluconazole) 10mg/ml powder for oral suspension
Diflucan® (fluconazole) 150mg capsules
Diflucan® (fluconazole) 200mg hard capsules
Diflucan® (fluconazole) 50mg hard capsules
Diflucan® (fluconazole) 40mg/ml powder for oral suspension
Tazocin (piperacillin sodium, tazobactam sodium) 2g/0.25g powder for solution for infusion
Tazocin (piperacillin sodium, tazobactam sodium) 4g/0.5g powder for solution for Infusion
- NHS England. Antifungal Stewardship Implementation Pack 2019. Available https://www.england.nhs.uk/wp-content/uploads/2019/03/PSS1-meds-optimisation-trigger-5-antifungal-stewardship-implementation-pack-v7.pdf. Accessed October 2020.
Free for Download
Antifungal Stewardship: Overview Booklet
For UK Healthcare Professionals*
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020
No